{
    "other_tests": [
        {
            "procedure_name": "Adrenocortical antibodies test",
            "date": "Not specified",
            "findings": "Adrenocortical antibodies were identified in all subjects.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "21-hydroxylase antibody test",
            "date": "Not specified",
            "findings": "21-hydroxylase antibodies were identified in all subjects.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "P450 side chain cleavage antibody test",
            "date": "Not specified",
            "findings": "P450 side chain cleavage antibodies were identified in all subjects.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Steroid cell antibody test",
            "date": "Not specified",
            "findings": "Steroid cell antibodies were positive in subjects 1 and 3.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "17-hydroxylase antibody test",
            "date": "Not specified",
            "findings": "17-hydroxylase antibodies were positive in subject 1 only.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Ultrasound for follicular assessment",
            "date": "Subject 1 underwent ultrasounds multiple times after GnRH treatment; specific dates not provided.",
            "findings": "Cycles resulted in the development of multiple dominant follicles; six in cycle 1, eight in cycle 2, and seven in cycle 3.",
            "changes_over_time": "Follicular development was consistent across cycles, but estradiol levels remained low despite increased follicle count."
        }
    ]
}